Kyntra Bio's top three insider shareholders as of September 09, 2026 are Thomas F Jr Kearns (Director, 39.76K shares), Gerald Lema (Director, 28.77K shares), Thane Wettig (Ceo, 27.00K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Thomas F Jr Kearns | Director | 39,764 | 0 | 39,764 | 27.9% | 17 Sep, 2021 |
| 2 | Gerald Lema | Director | 28,766 | 0 | 28,766 | 20.2% | 09 Jun, 2023 |
| 3 | Thane Wettig | Ceo | 27,005 | 0 | 27,005 | 19.0% | 09 Jun, 2026 |
| 4 | Enrique A Conterno | Chief Executive Officer | 14,989 | 0 | 14,989 | 10.5% | 10 Jul, 2023 |
| 5 | Christine Chung | Svp, China Operations | 11,796 | 0 | 11,796 | 8.3% | 07 Mar, 2025 |
| 6 | Mark Eisner | Evp, Chief Medical Officer | 6,397 | 0 | 6,397 | 4.5% | 08 Sep, 2023 |
| 7 | David Delucia | Chief Financial Officer | 4,377 | 0 | 4,377 | 3.1% | 09 Jun, 2026 |
| 8 | Deyaa Adib | Chief Medical Officer | 3,285 | 0 | 3,285 | 2.3% | 13 Jun, 2024 |
| 9 | Jeffrey L Edwards | Director | 1,359 | 0 | 1,359 | 1.0% | 09 Jun, 2023 |
| 10 | Maykin Ho | Director | 1,260 | 0 | 1,260 | 0.9% | 09 Jun, 2023 |
| 11 | Suzanne Blaug | Director | 1,184 | 0 | 1,184 | 0.8% | 09 Jun, 2023 |
| 12 | Benjamin Cravatt | Director | 1,149 | 0 | 1,149 | 0.8% | 09 Jun, 2023 |
| 13 | Aoife Brennan | Director | 1,118 | 0 | 1,118 | 0.8% | 09 Jun, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 12 Jun, 2026 | Maykin Ho | Director | Acquired A | 7,000 | $0.00 | $0 | 7,000 | Direct |
| 12 Jun, 2026 | Jeffrey L Edwards | Director | Acquired A | 7,000 | $0.00 | $0 | 7,000 | Direct |
| 12 Jun, 2026 | Michael Kauffman | Director | Acquired A | 7,000 | $0.00 | $0 | 7,000 | Direct |
| 12 Jun, 2026 | James A Schoeneck | Director | Acquired A | 7,000 | $0.00 | $0 | 7,000 | Direct |
| 06 Jun, 2026 | Thane Wettig | Ceo | Disposed F | 198 | $6.71 | $1.33K | 27,005 | Direct |
| 06 Jun, 2026 | David Delucia | Chief Financial Officer | Disposed F | 52 | $6.71 | $349 | 4,377 | Direct |
| 06 Mar, 2026 | David Delucia | Chief Financial Officer | Disposed F | 60 | $6.84 | $410 | 4,429 | Direct |
| 03 Feb, 2026 | David Delucia | Chief Financial Officer | Acquired A | 26,000 | $0.00 | $0 | 26,000 | Direct |
| 06 Dec, 2025 | David Delucia | Chief Financial Officer | Disposed F | 52 | $8.42 | $438 | 4,489 | Direct |
| 04 Jun, 2025 | Jeffrey L Edwards | Director | Acquired A | 120,000 | $0.00 | $0 | 4,800 | Direct |
| 04 Jun, 2025 | Maykin Ho | Director | Acquired A | 120,000 | $0.00 | $0 | 4,800 | Direct |
| 04 Jun, 2025 | Michael Kauffman | Director | Acquired A | 70,000 | $0.00 | $0 | 2,800 | Direct |
| 04 Jun, 2025 | Michael Kauffman | Director | Acquired A | 120,000 | $0.00 | $0 | 4,800 | Direct |
| 06 Mar, 2025 | Christine Chung | Svp, China Operations | Disposed F | 7,008 | $9.75 | $68.33K | 11,782 | Direct |
| 06 Mar, 2025 | David Delucia | Chief Financial Officer | Disposed F | 2,325 | $9.75 | $22.67K | 4,645 | Direct |
| 06 Mar, 2025 | Christine Chung | Svp, China Operations | Acquired A | 781 | $0.00 | $0 | 11,813 | Direct |
| 06 Mar, 2025 | Christine Chung | Svp, China Operations | Disposed F | 422 | $9.75 | $4.11K | 11,796 | Direct |
| 09 Jan, 2025 | David Delucia | Chief Financial Officer | Acquired A | 525,000 | $0.00 | $0 | 21,000 | Direct |
| 06 Dec, 2024 | Christine Chung | Svp, China Operations | Disposed F | 2,792 | $8.55 | $23.88K | 12,062 | Direct |
| 06 Dec, 2024 | Juan Graham | Chief Financial Officer | Disposed F | 1,446 | $0.34 | $495 | 165,929 | Direct |